About 300 reports

China’s demand for Anti-Obesity Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...

  • Obesity
  • China
  • Prescription Drug Sales
  • Labour Force

Major players in the anti-obesity market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, and Pfizer Inc., Merck & Co. Inc., Takeda Pharmaceuticals Company Limited, Eisai Co. Ltd. and Novo Nordisk A/S. The global antiobesity market is expected to grow from $2.73 billion in 2021 to $3.08 billion in 2022 at...

  • Obesity
  • World
  • Overweight Prevalence

Obesity (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Obesity - Drugs In Development, 2021, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape.Obesity is defined as having an excessive amount of...

  • Endocrine Disease
  • Obesity
  • World

Forecasts by Mechanism of Action (Incretin Mimetics/GLP-1 Agonists, Lipase Inhibitors, SNDRI’s, Serotonin Receptor Agonists, Sympathomimetic-GABA Receptor Agonists, Sympathomimetics, Others), by Type (Prescription Drugs, OTC Drugs), by Duration (Short-Term, Long-Term), by Distribution Channel (Hospitals, Retail, Online) AND Regional...

  • Obesity
  • World
  • Health Expenditure
  • Employment Income

Obesity Treatment market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Obesity Treatment Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Obesity Treatment types, applications. Further, Obesity Treatment...

  • Obesity
  • World

Anti-obesity Drugs market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Anti-obesity Drugs Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Anti-obesity Drugs types, applications. Further, Anti-obesity...

  • Obesity
  • World

Obesity Surgery Devices market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Obesity Surgery Devices Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Obesity Surgery Devices types, applications. Further,...

  • Obesity
  • World

Endoscopy Devices for Obesity, Type II Diabetes and NASH Market by Product (Endoscope, Mechanical Endoscopic Equipment, Visualization and Documentation Systems, Accessories, and Other Endoscopy Equipment), Procedure (Gastric Balloon, Aspiration Therapy, Endoscopic Sleeve Gastroplasty, Gastric Injection, and Lap Band Surgery), and Disease...

  • Endoscopic Device
  • Diabetes
  • Obesity
  • World
  • Overweight Prevalence
  • Drug Approval

Major players in the anti-obesity drugs market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, and Pfizer Inc. The global antiobesity market is expected to grow from $1.46 billion in 2020 to $2.4 billion in 2021 at a compound annual growth rate (CAGR) of 64.4%. The growth is mainly due to the companies rearranging...

  • Obesity
  • World
  • Overweight Prevalence

Abstract: - Global Anti-Obesity Drugs Market to Reach $5.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Anti-Obesity Drugs estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$5.1 Billion by 2027, growing at a CAGR of 19.4% over the period 2020-2027. -...

  • Obesity
  • World
  • United States
  • China
  • Japan

Anti-obesity Drugs Market Report Overview Anti-obesity Drugs market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Anti-obesity Drugs market types and applications. It is a focused study on Anti-obesity Drugs market space including global...

  • Obesity
  • World
  • Health Provider Density

Abstract: - Global Bariatric (Obesity) Surgical Devices Market to Reach $2.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Bariatric (Obesity) Surgical Devices estimated at US$1.4 Billion in the year 2020, is projected to reach a revised size of US$2.1 Billion by 2027, growing at a CAGR of 5.8%...

  • Surgical Equipment
  • Obesity
  • World
  • China
  • United States

Obesity - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Obesity - Pipeline Review, H2 2020, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape. Obesity is defined as having an excessive amount of body fat. Obesity...

  • Endocrine Disease
  • Obesity
  • World

Report Scope: This report aims to provide a comprehensive study of the global market for bariatric surgery, including services and devices. It provides a detailed description of the different types of bariatric procedures (invasive and noninvasive) and relevant devices. Bariatric procedures include sleeve gastrectomy,...

  • Obesity
  • World
  • Overweight Prevalence

Global Anti-obesity Drugs Market 2021-2025 The analyst has been monitoring the anti-obesity drugs market and it is poised to grow by $ 454.51 mn during 2021-2025 decelerate at a CAGR of 5% during the forecast period. Our reports on anti-obesity drugs market provides a holistic analysis, market size and forecast, trends,...

  • Obesity
  • World
  • Drug Approval
  • Overweight Prevalence

Body Fat Reduction Market by Procedure Type (Surgical and Non-Surgical), Gender (Male and Female), and End User (Hospitals & Clinics, Medical Spas, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030 The global body fat reduction market was valued at $7,587.77 million in 2020, and is projected...

  • Obesity
  • World
  • APAC
  • Overweight Prevalence

Abstract: - Global Human Microbiome Market to Reach $964.5 Million by 2027 - Amid the COVID-19 crisis, the global market for Human Microbiome estimated at US$391 Million in the year 2020, is projected to reach a revised size of US$964.5 Million by 2027, growing at a CAGR of 13.8% over the analysis period 2020-2027....

  • Diabetes
  • Obesity
  • Digestive System Disorder
  • Gastrointestinal Drug
  • World
  • China
  • United States

The Canada Spinal Surgery Devices market was anticipated to grow with a CAGR of 4.95%, during the forecast period. The major factors attributing to the growth of the Canada spinal surgery market are advancements in technology in spinal surgery equipment, growing aging and obese populace with growing number of spinal deformities, and increasing...

  • Prosthesis
  • Obesity
  • Canada
  • Ireland
  • Overweight Prevalence
  • Paid Claims

The Australian spinal surgery devices market is expected to register a CAGR of 5.1% during the forecast period. The propelling factors for the growth of the market include the increasing demand for minimally invasive surgical procedures, increasing incidence of obesity, aging population, and associated spine disorders. The continuous advancements...

  • General Medicine And Specialty Medicine
  • Obesity
  • World
  • Australia
  • Birth Rate
  • Life Expectancy

Major players in the body fat reduction market are AbbVie Inc. (Allergan Inc.), Apollo Hospitals Enterprise Limited, Cutera, Inc., Cynosure, Llc., Vlcc Health Care Limited, The Plastic Surgery Clinic, Bausch Health Companies Inc., Lumenis, Ltd., Sciton, Inc., Sisram Medical Ltd, Elite Body Sculpture, Fosun Pharmaceuticals Co. Ltd, VIDA Wellness...

  • Obesity
  • Health Insurance
  • World
  • APAC
  • United States
  • Australia
  • Overweight Prevalence

Obesity - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Obesity – Pipeline Review, H1 2020, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape. Obesity is defined as having an excessive amount of body fat. Obesity...

  • Endocrine Disease
  • Obesity
  • World

The global bioimpedance analyzers market size is projected to reach USD 767 million by 2026 from USD 429 million in 2021, at a CAGR of 10.2% from 2021 to 2026. Growth in this market is driven by the growing prevalence of lifestyle diseases such as obesity, increasing awareness on healthy lifestyles, and the growing number of fitness clubs,...

  • Obesity
  • Healthcare
  • Fitness
  • World
  • United States
  • North America
  • APAC
  • Overweight Prevalence
  • Diabetes Prevalence

KEY FINDINGS The global soft tissue repair market is evaluated to develop with a CAGR of 6.04% during the estimated years of 2021 to 2028. The market growth is predominantly credited to factors such as the prevalence of obesity, the increase in the geriatric population, the rising rates of sports injuries, and the surging...

  • Obesity
  • World
  • APAC
  • Overweight Prevalence

Laparoscopic Devices Market Size, Share & Trends Analysis Report By Product (Robot-assisted System, Energy Systems), By Application (Bariatric Surgery, Colorectal Surgery), By End-use, By Region, And Segment Forecasts, 2021 - 2028 Laparoscopic Devices Market Growth & Trends The global laparoscopic...

  • Obesity
  • World
  • North America
  • Surgical Procedures Performed

KEY FINDINGS The global non-alcoholic steatohepatitis (NASH) biomarker market is projected to grow with a CAGR of 20.65%, over the forecast period of 2021 to 2028. The market growth is mainly accredited to factors, such as, the rising NASH affected population, the surging awareness associated with non-alcoholic fatty liver...

  • Obesity
  • Hepatitis
  • Digestive System Disorder
  • Biomarker
  • Diabetes
  • Health Insurance
  • World
  • APAC
  • Overweight Prevalence
  • Diabetes Prevalence

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Fitness
  • Obesity
  • World
  • United States
  • China
  • Overweight Prevalence
  • Disposable Income

Global Anti-obesity Drugs Market Forecast 2020-2030: Mechanism of Action, Innovator Drugs, Generics. Prescription Drugs, OTC, Duration of Therapy, Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA Receptor Agonists, Sympathomimetics, Short-term Drugs, Long-term Drugs The...

  • Obesity
  • World

Global Anorexiants Market 2022-2026 The analyst has been monitoring the anorexiants market and it is poised to grow by $ 1.05 bn during 2022-2026 progressing at a CAGR of 4.62% during the forecast period. Our report on the anorexiants market provides a holistic analysis, market size and forecast, trends, growth drivers,...

  • Obesity
  • Pharmaceutical
  • World
  • Overweight Prevalence
  • Drug Approval

Non-Alcoholic Steatohepatitis - Epidemiology Forecast to 2029 Summary Non-alcoholic steatohepatitis (NASH) is a common, often clinically silent liver disease characterized by the presence of steatosis (fatty liver), in addition to liver inflammation and damage (NIDDK, 2016).Unlike alcoholic liver...

  • Obesity
  • Epidemiology
  • World
  • Overweight Prevalence
  • Prescription Drug Sales

Dietary Supplements Market Size, Share & Trends Analysis Report By Ingredient (Vitamins, Minerals), By Form, By Application, By End User, By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030 Dietary Supplements Market Growth & Trends The global dietary supplements market...

  • Dietary Supplement
  • Obesity
  • World
  • Overweight Prevalence
  • Disposable Income